Evidence map›Paper›PMID 38596359›Full record

ReviewFrontiers in cell and developmental biology2024

Chronic myeloproliferative neoplasms with concomitant

Magda Zanelli, Valentina Fragliasso, Giuseppe Gaetano Loscocco, Francesca Sanguedolce, Giuseppe Broggi, Maurizio Zizzo, Andrea Palicelli, Stefano Ricci, Elisa Ambrogi, Giovanni Martino and 11 more

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in cell and developmental biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Treatment ofAnnals of medicine and surgery (2012) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 10 institutions in 3 countries.

Magda ZanelliPathology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Valentina FragliassoLaboratory of Translational Research, Azienda USL-IRCCS di Reggio Emilia, Reggio Emila, Italy.
Giuseppe Gaetano LoscoccoDepartment of Experimental and Clinical Medicine, CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy.
Francesca SanguedolcePathology Unit, Policlinico Riuniti, University of Foggia, Foggia, Italy.
Giuseppe BroggiDepartment of Medical and Surgical Sciences and Advanced Technologies "G.F. Ingrassia" Anatomic Pathology, University of Catania, Catania, Italy.
Maurizio ZizzoSurgical Oncology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Andrea PalicelliPathology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Stefano RicciPathology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Elisa AmbrogiPathology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Giovanni MartinoPathology Unit, Azienda Ospedaliera Santa Maria di Terni, University of Perugia, Terni, Italy.
Sara AversaPathology Unit, Azienda Ospedaliera Santa Maria di Terni, University of Perugia, Terni, Italy.
Francesca CoppaPathology Unit, Azienda Ospedaliera Santa Maria di Terni, University of Perugia, Terni, Italy.
Pietro GentileOcular Immunology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Fabrizio GozziOcular Immunology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Rosario CaltabianoDepartment of Medical and Surgical Sciences and Advanced Technologies "G.F. Ingrassia" Anatomic Pathology, University of Catania, Catania, Italy.
Nektarios KoufopoulosSecond Department of Pathology, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.
Aleksandra AsaturovaPathology Department, FSBI "National Medical Research Centre for Ostetrics, Gynecology and Perinatology Named After Academician V.I Kulakov" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Luca CiminoOcular Immunology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Alberto CavazzaPathology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Giulio Fraternali OrcioniPathology Unit, Azienda Ospedaliera di Cuneo, Cuneo, Italy.
Stefano AscaniPathology Unit, Azienda Ospedaliera Santa Maria di Terni, University of Perugia, Terni, Italy.
Azienda Sanitaria Unità Locale di Reggio Emilia · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Perugia · ITOspedale G.F. Ingrassia · ITAzienda Ospedaliera S.Maria · ITAzienda Ospedaliero-Universitaria Careggi · ITAzienda Sanitaria Ospedaliera S.Croce e Carle Cuneo · ITNational and Kapodistrian University of Athens · GRNational Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of the Russian Federation · RUUniversity of Foggia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myeloproliferative neoplasms (MPNs) are subdivided into Philadelphia (Ph) chromosome-positive chronic myeloid leukemia (CML) and Ph-negative MPNs.

Indexed as

BCR::ABL1CALRchronic myeloid leukemiaessential thrombocythemiamyeloproliferative neoplasmprimary myelofibrosis

Identifiers

PMID38596359
PMCPMC11002177
OpenAlexW4393183405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.